Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Mar
28
2023
De-scheduling vs. Re-scheduling Marijuana: A Dramatic Difference Bradley Arant Boult Cummings LLP
Apr
18
2023
Federal Circuit Vaporizes Phillip Morris’s Obviousness Challenge in “a Close One” Bradley Arant Boult Cummings LLP
Jan
3
2024
Defending Psychedelics: Congress Includes Psychedelic Provisions in Defense Authorization Act Bradley Arant Boult Cummings LLP
Apr
4
2024
Proposal to Revamp Alabama Medical Cannabis Program Met with Near-Unanimous Opposition Bradley Arant Boult Cummings LLP
Apr
30
2024
DEA Poised to Reschedule Marijuana Bradley Arant Boult Cummings LLP
May
14
2021
Update on Medical Marijuana in Mississippi: COURT VOIDS INITIATIVE 65 Bradley Arant Boult Cummings LLP
Dec
1
2021
Same As It Ever Was: FDA Reiterates That CBD Cannot Be Included in Food or Dietary Supplements Bradley Arant Boult Cummings LLP
Jan
25
2022
Pot’s Progress in the Palmetto State Bradley Arant Boult Cummings LLP
Mar
16
2022
Looking into Our (Slightly Hazy) Crystal Ball: What Will the Mississippi Cannabis Market Look Like? Bradley Arant Boult Cummings LLP
Jun
1
2022
Getting into the Weeds: The Latest on the Alabama Medical Cannabis Program Bradley Arant Boult Cummings LLP
Jul
18
2022
The Waiting Is the Hardest Part: Alabama Medical Cannabis Commission Announces Updated Timetable for Licenses Bradley Arant Boult Cummings LLP
Jul
27
2022
Editors’ Roundtable: When Will Marijuana Be Federally Legal and What Will That Look Like? Bradley Arant Boult Cummings LLP
Oct
6
2022
Change (May) Come at Last? Biden Announces Review of Marijuana Scheduling and Mass Pardons for Simple Marijuana Possession Bradley Arant Boult Cummings LLP
Nov
9
2022
American Cannabis Policy Is the Definition of Insanity Bradley Arant Boult Cummings LLP
Oct
17
2023
The Roundabout: AMCC Litigation and Licensing Update Bradley Arant Boult Cummings LLP
Nov
20
2023
Big Brother Cancels Trip, Court Says Not So Fast My Friend Bradley Arant Boult Cummings LLP
Mar
21
2024
Legalizing LSD? FDA Says Mm-hmm to MM120 Bradley Arant Boult Cummings LLP
Jan
3
2022
Medical Marijuana Front and Center as Mississippi Lawmakers Reconvene for 2022 Legislative Session Bradley Arant Boult Cummings LLP
Jan
12
2022
Planting the Seeds: The Present State and Potential Prospects of Medical Cannabis in Tennessee Bradley Arant Boult Cummings LLP
May
11
2022
Congress Should Vote or Get off the Pot Bradley Arant Boult Cummings LLP
Jun
22
2022
The Weeds Thicken: Making Sense of the Ninth Circuit’s Decision Finding Delta-8 Legal Under Federal Law Bradley Arant Boult Cummings LLP
Feb
13
2023
Alabama Medical Cannabis: Deficiency Day Bradley Arant Boult Cummings LLP
May
13
2023
Up In Smoke: USPTO Leaves Cannabis-Related Trademark Application in Ashes Bradley Arant Boult Cummings LLP
Aug
16
2023
Fifth Circuit Upholds Marijuana User’s Second Amendment Rights – Will the Eleventh Circuit Do the Same? Bradley Arant Boult Cummings LLP
Aug
30
2023
COVID-19 Fall Outlook Bradley Arant Boult Cummings LLP
Nov
27
2023
Dude, Where’s My Liquidation? Bradley Arant Boult Cummings LLP
Jan
9
2024
Blazing Trails: Exploring ESOPs in the Cannabis Industry Bradley Arant Boult Cummings LLP
May
6
2021
In Historic Vote, Alabama House of Representatives Passes Medical Cannabis Bill Bradley Arant Boult Cummings LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins